Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Epeleuton

Generic Name: Epeleuton

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₃₄O_₃

CAS Number: 1667760-39-5

Unique Ingredient Identifier: FA9BPX1T6V

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients with Sickle Cell Disease

Phase 2

Recruiting

Posted: 2023/05/16

Sponsor:

Afimmune

ID:NCT05861453

Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes

Phase 2

Terminated

Posted: 2020/04/28

Sponsor:

Afimmune

ID:NCT04365400

Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease

Phase 2

Completed

Posted: 2018/01/30

Sponsor:

Afimmune

ID:NCT03414541

Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD

Phase 2

Completed

Posted: 2016/10/21

Sponsor:

Afimmune

ID:NCT02941549

Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects

Phase 1

Completed

Posted: 2016/02/04

Sponsor:DS Biopharma

ID:NCT02673593

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy